NCT03994497View on ClinicalTrials.gov

Evaluation of the Level of Expression of CD45RC on T Lymphocytes as a Predictive Biomarker of Acute Rejection After Renal Transplantation

NARecruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

February 2, 2025

Study Completion Date

February 2, 2026

Conditions

End-stage Renal Disease

Interventions

OTHER

Blood samples

Blood samples the day of the surgery and 4 times during the next year. Blood samples and histological slides taken at each biopsy and if there is suspicion of rejection of the graft

Trial Locations (1)

Unknown

RECRUITING

Dr Anne-Sophie GARNIER, Angers

All Listed Sponsors

lead

University Hospital, Angers

OTHER_GOV